Eric Sullivan's Net Worth
$2.25 Million
Who is Eric Sullivan?
Eric Sullivan has an estimated net worth of $2.25 Million. This is based on reported shares across multiple companies, which include bluebird bio, Inc., and TCR2 THERAPEUTICS INC..
SEC CIK
Eric Sullivan's CIK is 0001601797
Past Insider Trading and Trends
2015 was Eric Sullivan's most active year for acquiring shares with 21 total transactions. Eric Sullivan's most active month to acquire stocks was the month of July. 2015 was Eric Sullivan's most active year for disposing of shares, totalling 47 transactions. Eric Sullivan's most active month to dispose stocks was the month of June. 2017 saw Eric Sullivan paying a total of $464,789.62 for 20,019 shares, this is the most they've acquired in one year. In 2017 Eric Sullivan cashed out on 24,055 shares for a total of $1,364,443.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
bluebird bio, Inc. (BLUE) Snapshot price: $0.53
Principal Accounting Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$66.15 | -$47,660.57 | 5.67K |
Aug 3 - Aug 4
| |||
Form 4
| -11.44% | -733.00 |
$79.52 | -$277,454.90 | 5.67K |
Jul 5
| |||
Form 4
| -0.91% | -59.00 |
$72.79 | -$493,118.51 | 6.41K |
Jun 29
| |||
Form 4
|
∞
| 300 |
—
|
—
| 300 |
Apr 3
| |||
Form 4
| -5.98% | -411.00 |
$99.00 | -$40,689.00 | 6.47K |
Scheduled
|
Mar 16
| ||
Form 4
| -3.98% | -285.00 |
$89.00 | -$25,365.00 | 6.88K |
Scheduled
|
Feb 28
| ||
Form 4
| +32.34% | 1.75K |
—
|
—
| 7.16K |
Feb 1
| |||
Form 4
| -4.06% | -229.00 |
$67.10 | -$15,365.90 | 5.41K |
Jan 5
| |||
Form 4
|
—
|
0
|
$44.60 | -$18,633.65 | 5.64K |
Scheduled
|
Oct 3
| ||
Form 4
|
—
|
0
|
$40.60 | -$15,306.98 | 5.64K |
Scheduled
|
Sep 13
| ||
Form 4
|
—
|
0
|
$40.60 | -$15,306.98 | 5.64K |
Scheduled
|
Aug 3
| ||
Form 4
| +108.46% | 2.94K |
—
|
—
| 5.64K |
Aug 1
| |||
Form 4
|
—
|
0
|
$38.60 | -$95,518.91 | 2.71K |
Scheduled
|
Jul 27
| ||
Form 4
| -50.92% | -2.81K |
$45.04 | -$126,418.18 | 2.71K |
Scheduled
|
Jul 19 - Jul 20
| ||
Form 4
| +71.32% | 2.29K |
—
|
—
| 5.51K |
Mar 1
| |||
Form 4
|
—
|
0
|
$51.67 | -$24,514.31 | 3.22K |
Scheduled
|
Dec 2
| ||
Form 4
|
—
|
0
|
$50.04 | -$23,156.57 | 3.22K |
Scheduled
|
Nov 2
| ||
Form 4
|
—
|
0
|
$54.15 | -$26,582.49 | 3.22K |
Scheduled
|
Oct 2
| ||
Form 4
|
—
|
0
|
$76.57 | -$45,234.23 | 3.22K |
Scheduled
|
Sep 2
| ||
Form 4
|
—
|
0
|
$93.79 | -$59,564.52 | 3.22K |
Scheduled
|
Aug 3
| ||
Form 4
| -26.71% | -1.13K |
$163.36 | -$183,943.73 | 3.09K |
Scheduled
|
Jul 17 - Jul 20
| ||
Form 4
|
—
|
0
|
$92.84 | -$58,765.63 | 4.22K |
Scheduled
|
Jul 2
| ||
Form 4
|
—
|
0
|
$106.20 | -$69,884.68 | 316 |
Scheduled
|
Jun 2
| ||
Form 4
|
—
|
0
|
$77.02 | -$45,607.03 | 316 |
Scheduled
|
May 4
| ||
Form 4
|
—
|
0
|
$70.67 | -$282,661.11 | 316 |
Scheduled
|
Apr 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
$55.48 | -$258,963.48 |
0
|
Scheduled
|
Jan 2
| ||
Form 4
|
∞
| 3.9K |
—
|
—
| 3.9K |
Jul 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TCR2 THERAPEUTICS INC. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||